Cargando…
Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer
DNA repair defects have been increasingly focused on as therapeutic targets. In hormone-positive breast cancer, XRCC1-deficient tumors have been identified and proposed as targets for combination therapies that damage DNA and inhibit DNA repair pathways. XRCC1 is a scaffold protein that functions in...
Autores principales: | Lee, Kevin J., Piett, Cortt G., Andrews, Joel F., Mann, Elise, Nagel, Zachary D., Gassman, Natalie R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785058/ https://www.ncbi.nlm.nih.gov/pubmed/31596905 http://dx.doi.org/10.1371/journal.pone.0223725 |
Ejemplares similares
-
Exploiting DNA repair defects in triple negative breast cancer to improve cell killing
por: Lee, Kevin J., et al.
Publicado: (2020) -
REV7 Monomer Is Unable to Participate in Double Strand Break Repair and Translesion Synthesis but Suppresses Mitotic Errors
por: Vassel, Faye M., et al.
Publicado: (2023) -
The CHD6 chromatin remodeler is an oxidative DNA damage response factor
por: Moore, Shaun, et al.
Publicado: (2019) -
Sodium sulfide selectively induces oxidative stress, DNA damage, and mitochondrial dysfunction and radiosensitizes glioblastoma (GBM) cells.
por: Xiao, Adam Y., et al.
Publicado: (2019) -
Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons
por: Xu, Fenglian, et al.
Publicado: (2013)